Rhenman & Partners Asset Management AB Sells 20,000 Shares of Immunovant, Inc. (NASDAQ:IMVT)

Rhenman & Partners Asset Management AB decreased its position in shares of Immunovant, Inc. (NASDAQ:IMVT – Free Report) by 12.0% during the 4th quarter, HoldingsChannel.com reports. The fund owned 146,061 shares of the company’s stock after selling 20,000 shares during the period. Rhenman & Partners Asset Management AB’s holdings in Immunovant were worth $6,154,000 at […]

Related Keywords

Los Angeles ,California ,United States ,Juliag Butchko ,Eva Renee Barnett ,Securities Exchange Commission ,Jp Morgan Private Wealth Advisors ,Nasdaq ,Corecap Advisors ,Immunovant Inc ,Headlands Technologies ,Goldman Sachs Group ,Los Angeles Capital Management ,Cantor Fitzgerald ,Assetmark Inc ,Partners Asset Management ,Free Report ,Angeles Capital Management ,Private Wealth Advisors ,Cap Advisors ,Get Free Report ,Renee Barnett ,Exchange Commission ,Truist Financial ,Visit Holdingschannel ,Immunovant Daily ,